524 related articles for article (PubMed ID: 21277873)
1. Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes.
Gupta A; Bisht B; Dey CS
Neuropharmacology; 2011 May; 60(6):910-20. PubMed ID: 21277873
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function.
Takeda S; Sato N; Rakugi H; Morishita R
Mol Biosyst; 2011 Jun; 7(6):1822-7. PubMed ID: 21431241
[TBL] [Abstract][Full Text] [Related]
3. Intranasal administration of insulin lowers amyloid-beta levels in rat model of diabetes.
Subramanian S; John M
Indian J Exp Biol; 2012 Jan; 50(1):41-4. PubMed ID: 22279939
[TBL] [Abstract][Full Text] [Related]
4. Insulin receptor mutation results in insulin resistance and hyperinsulinemia but does not exacerbate Alzheimer's-like phenotypes in mice.
Murakami K; Yokoyama S; Murata N; Ozawa Y; Irie K; Shirasawa T; Shimizu T
Biochem Biophys Res Commun; 2011 May; 409(1):34-9. PubMed ID: 21549686
[TBL] [Abstract][Full Text] [Related]
5. Diabetes drugs in the fight against Alzheimer's disease.
Boccardi V; Murasecco I; Mecocci P
Ageing Res Rev; 2019 Sep; 54():100936. PubMed ID: 31330313
[TBL] [Abstract][Full Text] [Related]
6. Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.
Brunani A; Caumo A; Graci S; Castagna G; Viberti G; Liuzzi A
Diabetes Obes Metab; 2008 Jun; 10(6):460-7. PubMed ID: 17394563
[TBL] [Abstract][Full Text] [Related]
7. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
[TBL] [Abstract][Full Text] [Related]
8. Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia.
Genazzani AD; Lanzoni C; Ricchieri F; Baraldi E; Casarosa E; Jasonni VM
Gynecol Endocrinol; 2007 Mar; 23(3):146-52. PubMed ID: 17454168
[TBL] [Abstract][Full Text] [Related]
9. Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model.
Koopmans SJ; Mroz Z; Dekker R; Corbijn H; Ackermans M; Sauerwein H
Metabolism; 2006 Jul; 55(7):960-71. PubMed ID: 16784971
[TBL] [Abstract][Full Text] [Related]
10. The effect of metformin on measurements of insulin sensitivity and beta cell response in 18 horses and ponies with insulin resistance.
Durham AE; Rendle DI; Newton JE
Equine Vet J; 2008 Jul; 40(5):493-500. PubMed ID: 18482898
[TBL] [Abstract][Full Text] [Related]
11. Berberine ameliorates neuronal AD-like change via activating Pi3k/PGCε pathway.
Wu N; Liu W; Wang J; Han Y; Ye Y; Liu X; Yu Y; Chen Q; Bao Y; Liu C
Biofactors; 2021 Jul; 47(4):587-599. PubMed ID: 33740285
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
Roy S; Rauk A
Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
[TBL] [Abstract][Full Text] [Related]
13. Metabolic links between diabetes and Alzheimer's disease.
Maher PA; Schubert DR
Expert Rev Neurother; 2009 May; 9(5):617-30. PubMed ID: 19402773
[TBL] [Abstract][Full Text] [Related]
14. The antidiabetic effects of cysteinyl metformin, a newly synthesized agent, in alloxan- and streptozocin-induced diabetic rats.
Liu Z; Li J; Zeng Z; Liu M; Wang M
Chem Biol Interact; 2008 May; 173(1):68-75. PubMed ID: 18377884
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance and metformin in polycystic ovary syndrome.
Ben-Haroush A; Yogev Y; Fisch B
Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):125-33. PubMed ID: 15262344
[TBL] [Abstract][Full Text] [Related]
16. Effects of antidiabetic agents on Alzheimer's disease biomarkers in experimentally induced hyperglycemic rat model by streptozocin.
Ali SK; Ali RH
PLoS One; 2022; 17(7):e0271138. PubMed ID: 35802659
[TBL] [Abstract][Full Text] [Related]
17. Membrane physiology as a basis for the cellular effects of metformin in insulin resistance and diabetes.
Wiernsperger NF
Diabetes Metab; 1999 Jun; 25(2):110-27. PubMed ID: 10443322
[TBL] [Abstract][Full Text] [Related]
18. Metformin and pioglitazone: Effectively treating insulin resistance.
Staels B
Curr Med Res Opin; 2006; 22 Suppl 2():S27-37. PubMed ID: 16914073
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of metformin in normoglycemic morbidly obese adolescents.
Kay JP; Alemzadeh R; Langley G; D'Angelo L; Smith P; Holshouser S
Metabolism; 2001 Dec; 50(12):1457-61. PubMed ID: 11735093
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance and Alzheimer's disease: molecular links & clinical implications.
Neumann KF; Rojo L; Navarrete LP; Farías G; Reyes P; Maccioni RB
Curr Alzheimer Res; 2008 Oct; 5(5):438-47. PubMed ID: 18855585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
